Literature DB >> 26091720

Cutting Edge: IFN-γ Produced by Brain-Resident Cells Is Crucial To Control Cerebral Infection with Toxoplasma gondii.

Qila Sa1, Eri Ochiai1, Ashish Tiwari1, Sara Perkins1, Jeremi Mullins1, Marie Gehman1, William Huckle2, Willard H Eyestone3, Thomas L Saunders4, Brent J Shelton5, Yasuhiro Suzuki6.   

Abstract

In vitro studies demonstrated that microglia and astrocytes produce IFN-γ in response to various stimulations, including LPS. However, the physiological role of IFN-γ production by brain-resident cells, including glial cells, in resistance against cerebral infections remains unknown. We analyzed the role of IFN-γ production by brain-resident cells in resistance to reactivation of cerebral infection with Toxoplasma gondii using a murine model. Our study using bone marrow chimeric mice revealed that IFN-γ production by brain-resident cells is essential for upregulating IFN-γ-mediated protective innate immune responses to restrict cerebral T. gondii growth. Studies using a transgenic strain that expresses IFN-γ only in CD11b(+) cells suggested that IFN-γ production by microglia, which is the only CD11b(+) cell population among brain-resident cells, is able to suppress the parasite growth. Furthermore, IFN-γ produced by brain-resident cells is pivotal for recruiting T cells into the brain to control the infection. These results indicate that IFN-γ produced by brain-resident cells is crucial for facilitating both the protective innate and T cell-mediated immune responses to control cerebral infection with T. gondii.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26091720      PMCID: PMC4520543          DOI: 10.4049/jimmunol.1500814

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

Review 1.  The role of IFN-gamma in immune responses to viral infections of the central nervous system.

Authors:  David A Chesler; Carol Shoshkes Reiss
Journal:  Cytokine Growth Factor Rev       Date:  2002-12       Impact factor: 7.638

2.  Requirement of non-T cells that produce gamma interferon for prevention of reactivation of Toxoplasma gondii infection in the brain.

Authors:  H Kang; Y Suzuki
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  CXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii.

Authors:  Eri Ochiai; Qila Sa; Morgan Brogli; Tomoya Kudo; Xisheng Wang; Jitender P Dubey; Yasuhiro Suzuki
Journal:  Am J Pathol       Date:  2014-11-26       Impact factor: 4.307

Review 4.  Immune defence in mice lacking type I and/or type II interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; R M Zinkernagel; M Aguet
Journal:  Immunol Rev       Date:  1995-12       Impact factor: 12.988

Review 5.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

6.  The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic mice.

Authors:  S Dziennis; R A Van Etten; H L Pahl; D L Morris; T L Rothstein; C M Blosch; R M Perlmutter; D G Tenen
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

7.  Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism.

Authors:  C C Chao; W R Anderson; S Hu; G Gekker; A Martella; P K Peterson
Journal:  Clin Immunol Immunopathol       Date:  1993-05

8.  Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells.

Authors:  Tajie H Harris; Edward J Banigan; David A Christian; Christoph Konradt; Elia D Tait Wojno; Kazumi Norose; Emma H Wilson; Beena John; Wolfgang Weninger; Andrew D Luster; Andrea J Liu; Christopher A Hunter
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

9.  Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii.

Authors:  Elizabeth M Selleck; Sarah J Fentress; Wandy L Beatty; Daniel Degrandi; Klaus Pfeffer; Herbert W Virgin; John D Macmicking; L David Sibley
Journal:  PLoS Pathog       Date:  2013-04-25       Impact factor: 6.823

10.  Production of IL-8, IL-17, IFN-gamma and IP-10 in human astrocytes correlates with alphavirus attenuation.

Authors:  Bi-Hung Peng; Viktoriya Borisevich; Vsevolod L Popov; Michele A Zacks; D Mark Estes; Gerald A Campbell; Slobodan Paessler
Journal:  Vet Microbiol       Date:  2013-01-11       Impact factor: 3.293

View more
  17 in total

1.  A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18.

Authors:  Zhaoshou Yang; Yongheng Hou; Taofang Hao; Hee-Sool Rho; Jun Wan; Yizhao Luan; Xin Gao; Jianping Yao; Aihua Pan; Zhi Xie; Jiang Qian; Wanqin Liao; Heng Zhu; Xingwang Zhou
Journal:  Mol Cell Proteomics       Date:  2017-01-13       Impact factor: 5.911

Review 2.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

3.  Determination of a Key Antigen for Immunological Intervention To Target the Latent Stage of Toxoplasma gondii.

Authors:  Qila Sa; Eri Ochiai; Ashish Tiwari; Jeremi Mullins; Nilabh Shastri; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  J Immunol       Date:  2017-04-26       Impact factor: 5.422

Review 4.  The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.

Authors:  Yasuhiro Suzuki
Journal:  Parasitol Int       Date:  2019-11-25       Impact factor: 2.230

Review 5.  Organ-specific mechanisms linking innate and adaptive antifungal immunity.

Authors:  Rebecca A Drummond; Michail S Lionakis
Journal:  Semin Cell Dev Biol       Date:  2018-02-01       Impact factor: 7.727

Review 6.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

7.  The amino-terminal region of dense granule protein 6 of Toxoplasma gondii stimulates IFN-γ production by microglia.

Authors:  Qila Sa; Corinne Mercier; Marie-France Cesbron-Delauw; Yasuhiro Suzuki
Journal:  Microbes Infect       Date:  2020-01-20       Impact factor: 2.700

8.  Penetration of CD8+ Cytotoxic T Cells into Large Target, Tissue Cysts of Toxoplasma gondii, Leads to Its Elimination.

Authors:  Ashish Tiwari; Rancie Hannah; Jenny Lutshumba; Eri Ochiai; Louis M Weiss; Yasuhiro Suzuki
Journal:  Am J Pathol       Date:  2019-07-10       Impact factor: 4.307

9.  Robust Control of a Brain-Persisting Parasite through MHC I Presentation by Infected Neurons.

Authors:  Anna Salvioni; Marcy Belloy; Aurore Lebourg; Emilie Bassot; Vincent Cantaloube-Ferrieu; Virginie Vasseur; Sophie Blanié; Roland S Liblau; Elsa Suberbielle; Ellen A Robey; Nicolas Blanchard
Journal:  Cell Rep       Date:  2019-06-11       Impact factor: 9.423

10.  Inducible nitric oxide synthase in innate immune cells is important for restricting cyst formation of Toxoplasma gondii in the brain but not required for the protective immune process to remove the cysts.

Authors:  Qila Sa; Ashish Tiwari; Eri Ochiai; Jeremi Mullins; Yasuhiro Suzuki
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.